Nexalis Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is January - December.

Millions AUD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	0.44	0.19	0.72	2.13	2.8
Cash & Short-Term Investments	0.44	0.19	0.72	2.13	2.8
Cash Growth	124.15%	-72.77%	-66.45%	-23.90%	63.04%
Other Receivables	0.91	0.45	0.8	0.03	0.02
Receivables	0.91	0.45	0.8	0.03	0.02
Inventory	-	-	-	-	0.02
Prepaid Expenses	0.08	0.07	0.06	0.08	0.06
Other Current Assets	-	-	-	-	0
Total Current Assets	1.43	0.71	1.58	2.24	2.91
Property, Plant & Equipment	-	-	-	-	0.01
Other Intangible Assets	-	-	-	0.01	0.01
Total Assets	1.43	0.71	1.58	2.26	2.93
Accounts Payable	1.46	0.57	0.18	0.12	0.07
Accrued Expenses	0	-	0	0	-
Short-Term Debt	-	-	0.56	-	-
Current Portion of Long-Term Debt	0.43	0.03	-	-	-
Current Unearned Revenue	-	-	-	-	0.02
Other Current Liabilities	0.18	0.17	0.17	0.23	0.16
Total Current Liabilities	2.07	0.78	0.91	0.36	0.25
Long-Term Debt	0.32	-	-	-	-
Pension & Post-Retirement Benefits	0	0	0	-	-
Total Liabilities	2.38	0.78	0.91	0.36	0.25
Common Stock	15.15	14.53	14.08	13.93	12.9
Retained Earnings	-16	-14.38	-13.17	-11.73	-9.25
Comprehensive Income & Other	-0.1	-0.21	-0.24	-0.3	-0.97
Shareholders' Equity	-0.95	-0.06	0.67	1.9	2.68
Total Liabilities & Equity	1.43	0.71	1.58	2.26	2.93
Total Debt	0.74	0.03	0.56	-	-
Net Cash (Debt)	-0.3	0.16	0.16	2.13	2.8
Net Cash Growth	-	3.41%	-92.71%	-23.90%	63.04%
Net Cash Per Share	-0.00	0.00	0.00	0.01	0.02
Filing Date Shares Outstanding	239.36	213.45	189.77	187.27	168.47
Total Common Shares Outstanding	239.36	213.45	189.77	187.27	168.47
Working Capital	-0.63	-0.06	0.67	1.89	2.65
Book Value Per Share	-0.00	-0.00	0.00	0.01	0.02
Tangible Book Value	-0.95	-0.06	0.67	1.89	2.66
Tangible Book Value Per Share	-0.00	-0.00	0.00	0.01	0.02